Is Humana (HUM) an Undervalued Turnaround Play as Medicare Margins Recover?

3 weeks ago 25

Soumya Eswaran

Mon, August 3, 2026 astatine 9:22 AM CDT 3 min read

Diamond Hill Capital, a First Eagle Investment Management company, issued its Q2 2026 capitalist missive for its "Large Cap Strategy". A transcript of the missive is disposable to download here. The Strategy returned 3.42% nett of fees, trailing the Russell 1000 Value Index's 13.87% gain. Performance benefited from banal enactment successful user staples, materials and user discretionary, on with an underweight successful utilities. However, banal enactment successful accusation technology, wellness attraction and industrials detracted from comparative performance. AI remained the ascendant marketplace theme, driving an 81% summation successful technology, portion vigor declined aft the Iran warfare ended and lipid prices fell. The Strategy's constricted vulnerability to companies benefiting from AI-related superior spending caused astir of its underperformance, portion bundle holdings remained pressured by concerns astir AI disruption. Despite elevated marketplace valuations, the squad continues to find charismatic opportunities done bottom-up probe and expects progressive absorption to enactment better-than-market returns. In addition, delight cheque the Strategy's apical 5 holdings to cognize its champion picks successful 2026.

In its second-quarter 2026 capitalist letter, Diamond Hill Capital Large Cap Strategy highlighted Humana Inc. (NYSE:HUM) arsenic a recently added position. Humana Inc. (NYSE:HUM) is an American security institution that provides aesculapian and specialty security products. On July 31, 2026, Humana Inc. (NYSE:HUM) closed astatine $363.86 per share. The one-month instrumentality of Humana Inc. (NYSE:HUM) was -7.38%, and its shares gained 47.10% implicit the past 52 weeks. Humana Inc. (NYSE:HUM) has a marketplace capitalization of $43.69 billion.

Diamond Hill Capital Large Cap Strategy stated the following regarding Humana Inc. (NYSE:HUM) in its Q2 2026 capitalist letter:

"Health attraction services and security institution Humana Inc. (NYSE:HUM) is simply a caller holding successful 2Q26 and the second-largest Medicare Advantage insurer successful the US. Shares outperformed successful 2Q26 aft the institution delivered beardown 1Q26 results and connected better-than expected Medicare complaint increases announced successful aboriginal April, which volition beryllium adjuvant for the manufacture successful closing the spread betwixt pricing and outgo trends.

Health attraction services and security institution Humana is the second-largest Medicare Advantage insurer successful the US. Margins person been squeezed successful caller years from rising aesculapian costs and little authorities reimbursement; however, we judge margins volition normalize upward implicit clip arsenic the institution prices to bespeak higher utilization and arsenic authorities reimbursement rates improve. Relative to a much mean net base, we judge the valuation is very attractive."

Read Entire Article